Beijing Anti-Chuanglian Biopharmaceutical Technology Research Co., Ltd. is the research and development center of Shiyao Holding Group Co., Ltd. located in Beijing. Its business scope covers medical research and experimental development, technology development, transfer, consulting and service. The company has independent intellectual property rights and three authorized invention patents. The main research areas include cardiovascular and cerebrovascular, tumor, endocrine, neurological and psychiatric diseases, and the main research and development feature is the development of special preparations. Company registered capital of 5 million yuan, according to the regulations in Beijing Daxing District business tax.
Shiyao Holding Group Co., Ltd. is a national innovative enterprise integrating research and development, production and sales of innovative drugs.
At present, it has more than 10 drug production bases in Hebei, Shanxi, Shandong, Jiangsu, Jiangxi, Tianjin and other provinces and cities, and its products have been sold to more than 100 countries and regions around the world, with 36 varieties of single varieties selling more than 100 million yuan. Website address: http://www.e-cspc.com/about/index.html